Precision Therapeutics Enhances Their Straightforward Approach to Personalizing C... ( PITTSBURGH Jan. 24 2012 /- ...)

Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care

Date:1/24/2012

PITTSBURGH, Jan. 24, 2012 /PRNewswire/ -- Precision Therapeutics, Inc. has recently expanded their BioSpeciFx® product to include 21 clinically-relevant biomarkers to help physicians with their treatment decisions. This enhances Precision's approach to personalizing cancer care by offering additional molecular markers, including the recently FDA-approved ALK-FISH test. By utilizing BioSpeciFx® results in combination with Precision Therapeutics' ChemoFx® in vitro drug response marker, physicians will receive both molecular and live-cell drug response information about a patient's tumor. Through the integration of these two tests, physicians can create a Comprehensive Tumor Profile, allowing them to more completely define their patient's cancer. In an effort to personalize treatment selection even further, BioSpeciFx® and ChemoFx® tests give physicians the ability to choose from suggested tumor-specific panels or to customize a report for each patient.

"The decision to add new biomarker tests to Precision Therapeutics' Comprehensive Tumor Profile was a direct result of market trends and customer requests," says Sean McDonald, CEO. "Precision is committed to producing multiple products that help physicians make difficult clinical decisions throughout the cancer care continuum. We are in the process of developing several additional tools to help us adhere to our mission of improving the odds of survival and the quality of life for cancer patients."

About Precision Therapeutics
Precision Therapeutics, a leading life-science company based in Pittsburgh, Pennsylvania, is dedicated to personalized cancer care. Precision offers a portfolio of products developed to help guide physicians and patients with difficult clinical decisions throughout the cancer care continuum.

Precision's state of the art Comprehensive Tumor Profiling is an integrated straightforward approach combining three core platforms of
'/>"/>

SOURCE Precision Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
2. Applied Precision Announces New Products for Life Sciences Microscopy at the 110th American Society for Microbiology Meeting in San Diego, CA, May 23-26th.
3. Precision Bearing Technologies Featured at Atlantic Design & Manufacturing Show
4. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
5. Applied Precisions Mobile Imaging Lab Hits the Road for a Cross-Country Journey
6. Clinical Experts Detail How They Use Varians TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments
7. Precision Therapeutics President and CEO Sean McDonald Recognized as a Leading Business Executive and Recipient of 2010 Pacesetters Award
8. Applied Precision Installs a Record Four New DeltaVision OMX Super-Resolution Imaging Systems in Eight Weeks
9. Exempla Saint Joseph Hospital Commences Treating Cancer Patients Using New TrueBeam™ System for High-Precision Image-Guided Radiotherapy and Radiosurgery
10. Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico
11. Applied Precision Scientific Team to Present 3D-SIM Paper at BiOS in San Francisco

Post Your Comments:

(Date:6/17/2013)... As the Share Repurchase Resolution has been passed at ... Corporation, plc (NYSE: ELN ) has lapsed in ... Proceedings referred to below and any consequent decision of the ... to the extent that it would have been had it ... Repurchase Resolution being passed. There can be no assurance as ...

(Date:6/17/2013)... Mass. , and SYDNEY ... Inc. (Nasdaq: HTWR ; ASX: HIN), ... support technologies that are revolutionizing the treatment of ... Food and Drug Administration (FDA) has granted conditional ... that allows HeartWare to commence enrollment in an ...

(Date:6/17/2013)... Perrigo Company (NYSE: PRGO ; ... agreement to acquire and has completed the acquisition of ... Fera Pharmaceuticals, LLC and its affiliates (Fera), a privately-held, ... pharmaceutical company. The acquired portfolio, including nine prescription ANDA ... during calendar year 2012. Terms of the transaction include ...

[0] Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today [0] HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial [0] Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million

... YORK , Aug. 2 Reportlinker.com announces that a new market research report is ... Hepatitis C Therapeutics ... http://www.reportlinker.com/p0236386/Hepatitis-C-Therapeutics-Market---Taiwan.html , ... This research service aims to provide an update on ...

... SHANGHAI , Aug. 2 /PRNewswire-Asia/ -- WuXi ... a leading research and development outsourcing company serving the,pharmaceutical, ... the United States , today announced its financial ... . , (Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO ...

Hepatitis C Therapeutics Market - Taiwan WuXi PharmaTech Announces Second-Quarter 2010 Results

(Date:6/17/2013)... June 17, 2013 Nearly 26 million ... many as 79 million adults are estimated to have ... prevent type 2 diabetes through weight loss and lifestyle ... help bring your blood sugar level back within the ... factors, 101 Medical Weight Loss physicians can help tailor ...

(Date:6/17/2013)... NY (PRWEB) June 17, 2013 ... & Murphy, LLP are pleased to announce that ... and David L. Scher ( http://www.blockotoole.com/Attorneys/David-L-Scher.shtml ) will ... Z100 (100.3 FM) this Sunday, June 23, 2013 ... will be guests on Kevin Burke's "Get Active" ...

(Date:6/17/2013)... 17, 2013 The producers of Impact ... series of reports highlighting how sustainable farming techniques are ... populations and their demand on food supplies. , ... television series airing in markets around the country on ... Martin Sheen, who is marking the start of his ...

(Date:6/17/2013)... (PRWEB) June 17, 2013 Dallas-based physician ... the nation to offer the hybrid concierge model from ... model to offer her patients a wider variety of ... and a greater emphasis on prevention and wellness had ... who want a concierge-style of medicine, but doesn't force ...

(Date:6/17/2013)... Stem Cell Institute (HSCI) researchers have identified in the ... regulate embryonic stem cell self-renewal, beginning a creative search ... The gene, SALL4, gives stem cells their ability to ... cells. Typically, cells only express SALL4 during embryonic development, ... of acute myeloid leukemia and 10 to 30 percent ...

Breaking Medicine News(10 mins):Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 2 Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 3 Health News:Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss 4 Health News:Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital 2 Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 2 Health News:Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians 3 Health News:A new target for cancer drug development 2

[0] Best Diet Plans for Diabetics; Tips from 101 Medical Weight Loss [0] Injury Attorneys Block O'Toole & Murphy, LLP to Appear on Z100 Radio Show This Sunday to Discuss Their Support of St. Jude Children's Research Hospital [0] The Producers of Impact Martin Sheen for PBS Member Stations Announce a New Series on Sustainable Agriculture [0] Dr. Casad Offers Hybrid Concierge Model from Concierge Choice Physicians [0] A new target for cancer drug development

... its determination to gear up to meet the avian flu ... keep a close watch on bird flu cases and also ... M A Hakeem said "Though we have no cases of ... measures and the committee to be formed will include representatives ...

... a high childhood IQ irrespective of income and social position. ... and Laura Kubzansky, Harvard's School of Public Health who reported ... ,Childhood IQ of more than 163 score is very ... with a score more than 130 are considered gifted and ...

... cancers are mainly caused by cigarette smoking and smoking ... occurrence. In order to reduce the risk of cigarette ... of testing //their new range of “safer cigarette” which ... ,The company is testing their new ...

... practical and cost effective new way to combat the HIV ... modified bacteria living in the human body to produce chemicals ... occurs on the surfaces of the gut and reproductive areas, ... ,The researchers have successfully modified one of these bacteria ...

... age-related macular degeneration and the genetic mechanisms underlying the ... identification of a bacterium //called Chlamydia pneumoniae in the ... notable that the microorganism is associated with chronic inflammation ... in the diseased eye tissue of five of nine ...

... of bird flu in the famous Ranganathittu bird sanctuary ... Department today said that it was totally geared up ... ,The Department has taken precautionary measures against bird flu ... several countries including Central and Northern China, Russia, Mongolia, ...

Cached Medicine News:Health News:Avian Influenza: Government to set up expert committee 2 Health News:Genetically modified bacteria to combat HIV 2 Health News:Bird flu threat ruled out: Karnataka Forest Department, 2

Avian Influenza: Government to set up expert committee Intelligent children had longer live British company developing ‘Safer Cigarettes Genetically modified bacteria to combat HIV Vision Loss in Elderly Caused By Combined Effect of Genes and Bacterium Bird flu threat ruled out: Karnataka Forest Department,

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Retinol Binding Protein Restoril Respiratory Syncytial Virus DFA Reserpine, Serum or Plasma